Medicines for Malaria Venture Becomes First Product Development Partnership to Contribute Patents to the Pool for Open Innovation against Neglected Tropical Diseases - MarketWatch
Connotea Imports 2012-07-31
Summary:
" The Medicines for Malaria Venture (MMV) today became the first product development partnership (PDP) to contribute intellectual property to the Pool for Open Innovation against Neglected Tropical Diseases. MMV joins GlaxoSmithKline (GSK), Alnylam Pharmaceuticals, and the Massachusetts Institute of Technology (MIT) in contributing to the Pool....By emphasizing a more accessible approach to intellectual property and know-how, the Pool for Open Innovation against Neglected Tropical Diseases facilitates access to patents and/or technologies for organizations that want to conduct research on treatments for these neglected diseases...."